PVLA SCHEDULE 13G/A: SEC filing

Frazier Life Sciences Public Fund, L.P. and affiliated entities

Filed with the SEC on · accession 0001231919-26-001584

PVLA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 5.9% of Palvella Therapeutics' common stock, with the filing noting the shares exclude warrants held by the reporting persons.

Key details

Shares of common stock beneficially owned by Frazier Life Sciences Public Fund, L.P.$848K
Shares of common stock beneficially owned by Frazier Life Sciences X, L.P.$5K
Shares of common stock beneficially owned by Frazier Life Sciences XI, L.P.$9K
Shares of common stock beneficially owned by Frazier Life Sciences XII, L.P.$20K
IssuerPalvella Therapeutics, Inc.
Reporting person / beneficial ownerFrazier Life Sciences Public Fund, L.P.
Reporting person / affiliateFHMLSP, L.P.
Reporting person / affiliateFHMLSP, L.L.C.
Reporting person / affiliateFrazier Life Sciences X, L.P.
Reporting person / affiliateFHMLS X, L.P.
Reporting person / affiliateFHMLS X, L.L.C.
Reporting person / affiliateFrazier Life Sciences XI, L.P.
Reporting person / affiliateFHMLS XI, L.P.
Reporting person / affiliateFHMLS XI, L.L.C.
Reporting person / affiliateFrazier Life Sciences XII, L.P.
Reporting person / affiliateFHMLS XII, L.P.
Reporting person / affiliateFHMLS XII, L.L.C.
Reporting person (affiliate)James N. Topper
Reporting person (affiliate)Patrick J. Heron

✦ Ask GOAX AI about this filing — what it means for PVLA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PVLA?

Click here

Frequently asked questions

What did PVLA file with the SEC on Nov 16, 2026?

PVLA filed a SCHEDULE 13G/A (SEC filing). Frazier Life Sciences Public Fund, L.P. and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of approximately 5.9% of Palvella Therapeutics' common stock, with the filing noting the shares exclude warrants held by the reporting persons.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other PVLA SEC filings

Get alerts when PVLA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days